Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis

Overview of attention for article published in Cochrane database of systematic reviews, March 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (64th percentile)

Mentioned by

twitter: 1 X user

wikipedia: 1 Wikipedia page

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 38 Mendeley

Summary X Wikipedia Dimensions citations

So far, Dimensions has found 5 publications that cite this research output.

5

The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.

Extended stop codon context predicts nonsense codon readthrough efficiency in human cells

Article in Nature Communications (March 2024)

Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del)

Article in Cochrane Database of Systematic Reviews (November 2023)

A Chinese pediatric cystic fibrosis patient with the c.1624G>T, p. Gly542x/c.223C>T, p. Arg75x genotype

Article in Pediatric Pulmonology (September 2023)